SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-22-006742
Filing Date
2022-04-29
Accepted
2022-04-29 16:47:35
Documents
5
Period of Report
2022-06-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A janx_def_14a_2022.htm DEF 14A 892513
2 GRAPHIC img58054455_0.jpg GRAPHIC 63528
3 GRAPHIC img58054455_1.jpg GRAPHIC 63528
4 GRAPHIC img58054455_2.jpg GRAPHIC 58516
5 GRAPHIC img58054455_3.jpg GRAPHIC 37926
  Complete submission text file 0000950170-22-006742.txt   1201934
Mailing Address 11099 TORREY PINES PARK ROAD SAN DIEGO CA 92037
Business Address 11099 TORREY PINES PARK ROAD SAN DIEGO CA 92037 858-750-4700
Janux Therapeutics, Inc. (Filer) CIK: 0001817713 (see all company filings)

IRS No.: 822289112 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40475 | Film No.: 22876627
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences